Influences on the risk of recurrent high grade cervical abnormality

International Journal of Gynecological Cancer

Volumn 12, Issue 6, 2002, Pages 728-734

  Mitchell, Heather ^a   Hocking, J ^b  

^a Victorian Cervical Cytology Registry Melbourne   (Australia)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

Cervical neoplasia; Cohort; Kaplan Meier; Rate ratio

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER REGISTRY; CANCER SCREENING; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; INCIDENCE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; VICTORIA;

EID: 0036854287     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01153.x     Document Type: Article

References (19)

1. Quality Management Working Group. Cervical Cancer Prevention Network. Programmatic Guidelines for Screening for Cancer of the Cervix in Canada. Society of Gynecologic Oncologists of Canada., 1998: 20.
2. Commonwealth Department of Human Services and Health. Screening to prevent cervical cancer. In: Guidelines for the Management of Women with Screen Detected Abnormalities. Canberra: AGPS, 1994.
3. Cervical screening. In: Guidelines for the Management of Women with Abnormal Cervical Smears. National Cervical Screening Programme, 1998: 17.
4. Management of the patient with an abnormal cervical smear. Eur J Cancer 1993;29A (Suppl. 4):S12.
5. Achievable standards, benchmarks for reporting criteria for evaluating cervical cytopathology. Cytopath 1995;2 (Suppl.):15.
6. Mitchell H, Higgins V, Burrows C. Victorian Cervical Cytology Registry. Statistical Report 2000.
7. Canstat. Cancer in Victoria 1999. Cancer Epidemiology Centre, Anti-Cancer Council of Victoria. No 35, 2001.
8. The Working Party on Quality Assurance in Cervical Screening National Cervical Screening Program. The Australian (modified Bethesda) system for reporting gynaecological (cervical) cytology. Cytoletter 1996;December:23-7.
9. Kurman RJ, Solomon D.The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York: Springer-Verlag, 1994.
10. StatCorp. Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation. 1999.
11. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford: Oxford University Press, 1993.
12. Lubin JH, Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics 1984;40:63-75.
13. Bekassy Z. Long-term follow-up of cervical intraepithelial neoplasia treated with minimal conization by carbon dioxide laser. Lasers Surg Med 1997;20:461-6.
14. Mitchell MF, Tortolero-Luna G, Cook E, Whittaker L, Rhodes-Morris H, Silva E. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998;92:737-44.
15. Pettersson F, Malker B. Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma. Record linkage study with a National Cancer Registry. Radiotherap Oncol 1989;16:115-20.
16. Levi F, Randimbison L, La Vecchia C, Franceschi S. Incidence of invasive cancers following carcinoma in situ of the cervix. Br J Cancer 1996;74:1321-3.
17. Soutter WP, de Barros Lopes A, Fletcher A et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:978-80.
18. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-8.
19. Vikki M, Pukkala E, Hakama M. Risk of cervical cancer subsequent to a positive screening cytology: Follow-up study in Finland. Acta Obstet Gynecol Scand 2000;79:576-9.